Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Leuprolide Mesylate (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Urology Centers of Alabama
  Homewood, Alabama, United States
  Site recruitment: Not reported
• Alliance Research Centers
  Laguna Hills, California, United States
  Site recruitment: Not reported
• Genesis Research, LLC
  San Diego, California, United States
  Site recruitment: Not reported
• Idaho Urologic Institute - Meridian
  Meridian, Idaho, United States
  Site recruitment: Not reported
• AdvanceMed Research
  Lawrenceville, New Jersey, United States
  Site recruitment: Not reported
• Carolina Clinical Trials, LLC
  Concord, North Carolina, United States
  Site recruitment: Not reported
• Carolina Urologic Research Center
  Myrtle Beach, South Carolina, United States
  Site recruitment: Not reported
• Seattle Urology Research Center
  Burien, Washington, United States
  Site recruitment: Not reported
• AKH Linz GmbH, Department of Urology
  Linz, Upper Austria, Austria
  Site recruitment: Not reported
• Universitätsklinik für Urologie und Andrologie, Landeskrankenhaus Salzburg (University hospital for Urology and Andrology)
  Salzburg, Austria
  Site recruitment: Not reported
• Thomayerova nemocnice Urologické oddělení
  Prague, Praha 4 - Krč, Czechia
  Site recruitment: Not reported
• University Hospital Hradec Králové
  Hradec Králové, Czechia
  Site recruitment: Not reported
• University Hospital Olomouc
  Olomouc, Czechia
  Site recruitment: Not reported
• Universitätsklinikum RWTH Aachen, Klinik für Urologie
  Aachen, North Rhine-Westphalia, Germany
  Site recruitment: Not reported
• PI Hospital of Lithuanian University of Health Sciences, Kauno Klinikos
  Kaunas, Lithuania
  Site recruitment: Not reported
• PI Klaipėda University Hospital
  Klaipėda, Lithuania
  Site recruitment: Not reported
• PI Vilnius University Hospital, Santariškių Klinikos
  Vilnius, Lithuania
  Site recruitment: Not reported
• Centralny Szpital Kliniczny MSW w Warszawie, Klinika Urologii i Urologii Onkologicznej
  Warzawa, Warzawa, Poland
  Site recruitment: Not reported
• Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie Klinika Nowotworów Układu Moczowego
  Warzawa, Warzawa, Poland
  Site recruitment: Not reported
• Uniwersyteckie Centrum Kliniczne, Klinika Urologii
  Gdansk, Poland
  Site recruitment: Not reported
• "DERMED" Centrum Medyczne Sp. z o.o.
  Lodz, Poland
  Site recruitment: Not reported
• UROCENTRUM MILAB, s.r.o.
  Prešov, Slovakia
  Site recruitment: Not reported
• Fakultná nemocnica s poliklinikou Žilina Urológia
  Žilina, Slovakia
  Site recruitment: Not reported
• Kaohsiung Veteran General Hospital (VGHKS)
  Kaohsiung City, Pingtung, Taiwan
  Site recruitment: Not reported
• China Medical University Hospital (CMUH)
  Taichung, Taichung, Taiwan
  Site recruitment: Not reported
• Taichung Veteran General Hospital (VGHTC)
  Taichung, Taichung, Taiwan
  Site recruitment: Not reported
• National Cheng Kung University Hospital (NCKUH)
  Tainan, Tainan, Taiwan
  Site recruitment: Not reported
• National Taiwan University Hospital (NTUH)
  Taipei City, Taipei, Taiwan
  Site recruitment: Not reported
• Chang Gung Memorial Hospital, LinKou (CGMH-LK)
  Taoyuan City, Taiwan
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Goserelin Acetate (drug) — also listed as: ZDX, Zoladex
• Laboratory Biomarker Analysis (other)
• Leuprolide Acetate (drug) — also listed as: A-43818, Abbott 43818, Abbott-43818, Carcinil, Depo-Eligard, Eligard, Enanton, Enantone, Enantone-Gyn, Ginecrin, LEUP, Leuplin, Leuprorelin Acetate, Lucrin, Lucrin Depot, Lupron, Lupron Depot, Lupron Depot-3 Month, Lupron Depot-4 Month, Lupron Depot-Ped, Procren, Procrin, Prostap, TAP-144, Trenantone, Uno-Enantone, Viadur
• Vismodegib (drug) — also listed as: Erivedge, GDC-0449, Hedgehog Antagonist GDC-0449

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• University of Michigan Comprehensive Cancer Center
  Ann Arbor, Michigan, United States
  Site recruitment: Not reported
• Wayne State University/Karmanos Cancer Institute
  Detroit, Michigan, United States
  Site recruitment: Not reported
• Duke University Medical Center
  Durham, North Carolina, United States
  Site recruitment: Not reported
• M D Anderson Cancer Center
  Houston, Texas, United States
  Site recruitment: Not reported
• University of Wisconsin Hospital and Clinics
  Madison, Wisconsin, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Treatment with a GnRh agonists (drug) — also listed as: histrelin acetate 50mg (SUPPRELIN LA®), l(LUPRON DEPOT®) 30 mg for 3-month injections

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• University of California, San Francisco
  San Francisco, California, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Leuprorelin (drug)
• Levonorgestrel (device)
• Dienogest (drug)
• Progestins (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Peng-Hui Wang
  Taipei County, Taipei, Taiwan
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Leuprolide acetate, Bicalutamide, Sorafenib (drug) — also listed as: Leuprolide acetate, Bicalutamide, Sorafenib

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• St.Luke's-Roosevelt Hospital Center
  New York, New York, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• GnRH agonist (drug) — also listed as: leuprolide acetate,, lupron
• hCG (drug) — also listed as: Pregnyl

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• UCHC Division of Reproductive Endocrinology
  Farmington, Connecticut, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Exemestane Tablets (drug)
• ovarian function suppression/ablation (other)
• CYP2D6*10 gene test (genetic)
• Tamoxifen (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• CancerIHCAMS
  Beijing, Beijing Municipality, China
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Eligard (TM) (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Enzalutamide (drug) — also listed as: MDV3100
• Leuprolide (drug)
• Dutasteride (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Facility not reported
  Boston, Massachusetts, United States
  Site recruitment: Not reported
• Facility not reported
  Seattle, Washington, United States
  Site recruitment: Not reported
• Facility not reported
  Vancouver, British Columbia, Canada
  Site recruitment: Not reported
• Facility not reported
  Toronto, Ontario, Canada
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• University of Minnesota
  Minneapolis, Minnesota, United States
  Site recruitment: Not reported
• Atlantic Center for Research
  Morristown, New Jersey, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Exemestane (drug) — also listed as: Aromasin
• Letrozole (drug) — also listed as: Femara
• Anastrozole (drug) — also listed as: Arimidex
• Leuprolide Acetate (drug) — also listed as: Lupron, Lupron Depot
• Pertuzumab (drug) — also listed as: Perjeta
• Trastuzumab (drug) — also listed as: Herceptin

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Southeastern Regional Medical Center
  Newnan, Georgia, United States
  Site recruitment: Not reported
• Cancer Treatment Centers of America at Midwestern Regional Medical Center
  Zion, Illinois, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Long GnRH agonist protocol (drug) — also listed as: Leuprolide acetate ( Lupron)
• Embryo transfer (procedure)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Kasr Alainy medical school
  Cairo, Egypt
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Tamoxifen (drug)
• Tamoxifen and GnRH analogue (drug) — also listed as: TRENATONE, ZOLADEX
• Exemestane and GnRH analogue (drug) — also listed as: AROMASIN, TRENATONE, ZOLADEX.

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Kliniken Essen-Mitte
  Essen, North Rhine-Westphalia, Germany
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Leuprolide acetate (drug) — also listed as: Lupron

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Massachusetts General Hospital
  Boston, Massachusetts, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Leuprorelin Acetate Depot (drug) — also listed as: Prostap SR
• Elagolix (drug) — also listed as: NBI-56418, Orilissa™
• Placebo to Elagolix (drug)
• Placebo to Leuprorelin Acetate (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Lutrate (drug)
• Enantone (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• The First Affiliated Hospital of Bengbu Medical College
  Bengbu, Anhui, China
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Flutamide (drug) — also listed as: Eulexin
• Leuprolide Acetate (drug) — also listed as: Lupron Depot, Eligard, Lupron

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Seattle Cancer Care Alliance
  Seattle, Washington, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Exisulind (drug) — also listed as: Aptosyn
• luteinizing hormone-releasing hormone (LHRH) agonist (drug) — also listed as: Lupron, Zoladex
• Antiandrogen (drug) — also listed as: Eulexin, Casodex

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Seattle Cancer Care Alliance
  Seattle, Washington, United States
  Site recruitment: Not reported